MIMIVAX VARIA VENTURES LLC

BUFFALO, NY · Founded 2019 · CIK 0001784650 · Biotech · Private

SurVaxM, a peptide mimic immunotherapeutic vaccine targeting survivin for cancer treatment

mimivax.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$10M
1 Form D · Aug 2019
86 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$10,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1578ANOVAC, INC.——
1579Vesalius Therapeutics——
1580Immunova Therapeutics LLC——
1581MIMIVAX VARIA VENTURES LLC—$10M
1582PARMEDICS, INC——
1583Versa Integrated Solutions, Inc.——
1584Stem Biotech LLC—$100M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • N/A Varia Ventures Management Group, LLCExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.